Invention Grant
- Patent Title: PDE4 inhibitor (R)-4-(5-(4-methoxy-3-propoxyphenyl)pyridin-3-yl)-1,2-oxaborolan-2-ol
-
Application No.: US16593171Application Date: 2019-10-04
-
Publication No.: US10946031B2Publication Date: 2021-03-16
- Inventor: Joseph Walter Strohbach , David Clive Blakemore , Peter Jones , Matthew Alexander Perry
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent James T. Wasicak
- Main IPC: C07F5/02
- IPC: C07F5/02 ; A61K31/69 ; A61K31/519
Abstract:
The present invention relates to PDE4 inhibitor (R)-4-(5-(4-methoxy-3-propoxyphenyl)pyridin-3-yl)-1,2-oxaborolan-2-ol including the crystalline monohydrate thereof.
Information query
